All medicinal products authorized in the European Union are subjects of constant drug-
safety monitoring processes. It is organized in a pharmacovigilance system that is designed …

Abstract Background Only 5–10% of all adverse drug reactions (ADRs) are reported.
Mechanisms to support patient and public reporting offer numerous advantages to health …

Introduction Patient reporting in pharmacovigilance is important and contributes to signal
detection. However, descriptions of methodologies for using patient reports in signal …

Patients who report suspected adverse drug reactions (ADRs) help minimize drug safety
risks and bolster the pharmacovigilance system. The aim of this study was to examine the …

BACKGROUND: To improve the public health and promote instant adverse drug reaction
(ADR) reporting, a need to develop an ADR Pharmacovigilance Programme of India (PvPI) …

Background: Endometriosis, which affects 1 in 10 people assigned female at birth, is a
chronic systemic inflammatory disease with a high symptom burden and adverse …

Background Higher incidence of adverse drug reactions (ADRs) remain a major cause of
morbidity and mortality. Most targeted ADR reporting activities are mainly professional …

Introduction Vortioxetine, a multimodal serotonergic drug, is widely used as treatment for
major depressive disorder. Although on the market since late 2013, the data of the relative …

ABSTRACT Introduction: In April 2003, the Netherlands Pharmacovigilance Centre Lareb
successfully implemented patient reporting to their spontaneous reporting system. The …

Abstract Background The number of Individual Case Safety Reports (ICSRs) in
pharmacovigilance databases are rapidly increasing world‐wide. The majority of ICSRs at …